BM 06.022

a t-PA mutant produced in E coli by DNA technology; promises to induce fewer hemorrhagic complications than either t-PA or streptokinase
Also Known As:
BM 06022; BM-06.022
Networked: 12 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1. Coronary Thrombosis
2. Renal Insufficiency (Renal Failure)
3. Myocardial Infarction
4. Thrombosis (Thrombus)
5. Coronary Occlusion

Related Drugs and Biologics

1. Tissue Plasminogen Activator (Alteplase)
2. KHRR 296-299 AAAA T103N
3. Plasminogen Activators (Plasminogen Activator)
4. Urokinase-Type Plasminogen Activator (Urokinase)
5. Anistreplase (APSAC)
6. Streptokinase
7. Sodium Chloride (Saline Solution)
8. Hirudins
9. Heparin (Liquaemin)
10. olive oil